A health worker draws a dose of the AstraZeneca coronavirus vaccine. Photo: Reuters A health worker draws a dose of the AstraZeneca coronavirus vaccine. Photo: Reuters
A health worker draws a dose of the AstraZeneca coronavirus vaccine. Photo: Reuters

AstraZeneca coronavirus vaccine has good risk-benefit profile for over 60s, says European Medicines Agency

  • It was reported the European Medicines Agency (EMA) task force chief had said countries should avoid giving the vaccine to people over 60 amid blood clot fears
  • The EMA’s Marco Cavaleri said the AstraZeneca vaccine ‘maintains a favourable benefit risk profile in all ages but particularly in the elderly above 60’

Topic |   Coronavirus pandemic
A health worker draws a dose of the AstraZeneca coronavirus vaccine. Photo: Reuters A health worker draws a dose of the AstraZeneca coronavirus vaccine. Photo: Reuters
A health worker draws a dose of the AstraZeneca coronavirus vaccine. Photo: Reuters
READ FULL ARTICLE